Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity

NCT05610020 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2022-11-08

No results posted yet for this study

Summary

the aim of the study is to correlate between the severity of sepsis and serum heparin binding protein in the patients admitted to ICU with sepsis., and detect its value as a prognostic biomarker in sepsis

Conditions

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-08-01
Completion
2022-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05610020 on ClinicalTrials.gov